… the development and use for marketed monoclonal antibodies (mAbs) and antibody–drug conjugates (ADCs) of two-dimensional … environment. In recent years, monoclonal antibodies (mAbs) and antibody–drug conjugates (ADCs) have emerged as … companies in the development, release, and control of their mAbs and ADCs, in a regulated environment (such as the …

… Terral, A. Beck, and S. Cianferani,  J Chromatogr. B , in press. R. Gahoual, A. Beck, Y.N. François, and E. … Veuthey, A Beck, and D. Guillarme,  J Chromatogr. B , in press. M. Rodriguez-Aller, A. Cusumano, A Beck, D. Guillarme, and S. Fekete, J Chromatogr. B , in press. M. Sarrut, A. Corgier, S. Fekete, D. Guillarme, D. …